جست‌وجوی استاد و پژوهشگر

• Health Economics
• Medical Decision Making
• Public Health Policy
• +۴ مورد دیگر

Prof. Thomas Mayrhofer is a Professor of Economics at Stralsund University of Applied Sciences since 2015 and concurrently serves as Lecturer at Harvard Medical School. He holds a doctorate in Health Economics from the University of Duisburg-Essen, after studying Economics at Otto-von-Guericke University Magdeburg. His career includes research roles at CINCH (Essen) and Massachusetts General Hospital (Boston). Education: PhD in Health Economics (University of Duisburg-Essen) MSc Economics (Otto-von-Guericke University) Research Focus: Health Economics Medical Decision Theory Cardiovascular Disease Pathophysiology Atherosclerosis Mechanisms Imaging Biomarkers Sustainability in Healthcare Key Article Trends: Recent work emphasizes cardiovascular outcomes in HIV populations (REPRIEVE Trial), epicardial adipose tissue imaging, air pollution-cardiovascular links (PROMISE Trial), and preterm infant neurodevelopment. His research bridges clinical medicine and economic decision frameworks. Labs/Teams: Collaborates with Harvard Medical School's cardiovascular imaging group and CINCH Health Economics Research Center.

Diana Bautistaمشاهده پروفایل

استاد

• Sensory Biology
• Neuroscience
• Molecular Biology
• +۶ مورد دیگر

Diana Bautista is a Professor specializing in cellular and molecular mechanisms of touch and pain. Her research focuses on sensory transduction in somatosensory neurons, particularly exploring TRP channels, mechanosensation, and the pathophysiology of chronic pain/itch. As a Howard Hughes Investigator and CDP Division Head, she leads the SENse Lab (co-PI with Ellen Lumpkin), studying neuroimmune interactions in skin and epithelial tissues. Research Interests: Touch transduction, TRP channel function, inflammatory pain/itch, star-nosed mole somatosensation, and atopic dermatitis mechanisms. Lab: SENse Lab - investigates sensory systems using molecular genetics, electrophysiology, and behavioral assays. Major Projects: Mechanosensory neuron assays, light-touch receptor biology, mole mechanotransduction, and pruritis signaling. Key contributions include discovering sanshool's tingling mechanism via TRPV1/TRPA1 channels, and identifying S1PR3/TRPA1 pathways in itch/pain. Her work bridges basic science with translational research in chronic sensory disorders.

• Immunology
• T Cell Biology
• CD4 T Cell Memory
• +۵ مورد دیگر

Susan L. Swain is a distinguished Professor of Pathology at UMass Chan Medical School, holding multiple appointments across the T.H. Chan School of Medicine and Morningside Graduate School of Biomedical Sciences. Her academic journey spans over four decades, beginning at UCSD where she rose from Lecturer to Professor of Biology in Residence, followed by leadership roles as Director and President of the Trudeau Institute, before joining UMass Medical School in 2010. Dr. Swain's research focuses on the cellular and molecular mechanisms of CD4 T cell immunity, with particular emphasis on T cell memory formation, cytotoxic CD4 effectors, and age-related immune deficiencies. Her laboratory has made seminal contributions to understanding how memory CD4 T cells provide protection against influenza infection and how aging affects T cell function. Current research priorities include discovering new mechanisms used by memory CD4 T cells for effective immunity and defining age-associated defects to develop strategies to overcome them. Analysis of Dr. Swain's recent publications reveals a consistent focus on CD4 T cell memory checkpoints, the requirements for generating protective memory cells, and the impact of aging on immune responses. Her work demonstrates that persistent infection signals at effector checkpoints determine memory cell fates, and that age-associated B cells play critical roles in immune responses in the elderly. The research has significant implications for improving vaccine efficacy in aging populations. Among her notable honors are the NIH Merit Award (awarded twice), New York State Woman of Distinction, and the American Association of Immunologists Lifetime Achievement Award. She previously served as President of the American Association of Immunologists (2004) and has held numerous editorial positions including Deputy Editor of the Journal of Immunology. Dr. Swain actively mentors students through rotation projects focusing on CD4 T cell memory, cytotoxic CD4 effectors, and aging immunity. Her laboratory provides opportunities for postdoctoral researchers interested in T cell memory development and survival. She has served on numerous national advisory boards including the National Advisory Council on Aging (2008-2012) and the Scientific Advisory Board of the La Jolla Institute of Allergy and Immunology.

• Innate Immunity
• Inflammasome Biology
• Nucleic-Acid Sensing
• +۶ مورد دیگر

Katherine A. Fitzgerald, PhD , is Professor and Vice Chair of Medicine at the University of Massachusetts Chan Medical School , where she also serves as Chief of the Division of Innate Immunity and holds the Worcester Foundation for Biomedical Research Chair III . She is cross-appointed in multiple graduate programs at the Morningside Graduate School of Biomedical Sciences , including Immunology and Microbiology, Translational Science, MD/PhD, and Post-baccalaureate Research Education. Education B.Sc. in Biochemistry, University College Cork, Ireland (1995) Ph.D. in Biochemistry, Trinity College Dublin, Ireland (1999) Research Focus Dr. Fitzgerald’s work is centered on the molecular basis of innate immunity , dissecting how nucleic-acid sensors, inflammasomes, and long non-coding RNAs orchestrate inflammatory responses during infection and in chronic inflammatory diseases. Her laboratory aims to translate these insights into therapeutic strategies for infectious, autoimmune, and autoinflammatory disorders. Scientific Honors Member, National Academy of Sciences (USA) Member, National Academy of Medicine (USA) Member, Royal Irish Academy Fellow, American Academy of Microbiology Thermo-Fisher Meritorious Career Award (2022) Saint Patrick’s Day Medal (2015) Milstein Award for Excellence in Interferon and Cytokine Research (2014) Leadership & Service Past President of the International Cytokine and Interferon Society, she serves on national advisory boards including NIAID’s Board of Scientific Councillors and the Massachusetts Center for Pathogen Readiness. Laboratory & Training Her Fitzgerald Lab (Program in Innate Immunity) welcomes graduate rotation students; interested applicants should contact Kate.Fitzgerald@umassmed.edu .

• Immunology
• Rheumatology
• Applied Immunology
• +۸ مورد دیگر

Dr. Andrew Craig is an Associate Professor in the Department of Biomedical and Molecular Sciences at Queen's University, affiliated with the Faculty of Health Sciences and the Queen’s Cancer Research Institute. He holds cross appointments in the Cancer Biology & Genetics division and the Translational Institute of Medicine (TIME). He earned his PhD in Biochemistry from McGill University (1998) and completed postdoctoral training at Queen's University before joining the faculty in 2002. His research focuses on molecular mechanisms of cancer progression, immune suppression, and metastasis, with a particular emphasis on tumor suppressor miRNAs, actin-driven metastasis, and immunotherapy strategies. Education: PhD in Biochemistry, McGill University (1998) BSc in Biochemistry, Queen's University (1993) Research Interests: Dr. Craig’s work spans immunology, oncology, and cellular biology. Key areas include: Inflammatory mechanisms and inflammasomes Cancer immunotherapy and metastasis TGF-β signaling pathways MicroRNA biomarkers in lung cancer Actin-targeting compounds for cancer treatment Research Highlights: His lab has developed novel synthetic antibodies targeting TGF-β to improve chemotherapy efficacy in ovarian cancer models. Recent studies focus on functional genomic screening to identify vulnerabilities in inflammatory breast cancer and defining miRNA biomarkers in immunotherapy-treated patients. His work integrates advanced techniques like confocal microscopy and flow cytometry. Awards: Canadian Cancer Society Young Investigator Award (2011) Grants & Funding: Dr. Craig maintains continuous external funding for his research, supported by grants from agencies such as the Canadian Cancer Society and the Canadian Institutes of Health Research (CIHR). Labs & Affiliations: He leads the Craig Lab within the Department of Biomedical and Molecular Sciences and collaborates with the Queen’s Cancer Research Institute and Translational Institute of Medicine (TIME). His research bridges basic science and clinical translation, emphasizing preclinical models of disease and precision medicine approaches.

Durjoy Lahiriمشاهده پروفایل

استادیار

• Alzheimer’s Disease
• Fluid Biomarkers
• Neuromodulation Techniques (e.g., tDCS)
• +۶ مورد دیگر

Dr. Durjoy Lahiri is an Assistant Professor in the Department of Medicine at Queen’s University, affiliated with the Faculty of Health Sciences. He holds a MBBS, MD, and DM from institutions in India, including Nil Ratan Sircar Medical College and the Institute of Postgraduate Medical Education and Research (IPGME&R). His clinical expertise spans primary cognitive and behavioral disorders (e.g., Alzheimer’s Disease, Fronto-Temporal Dementia) and cognitive dysfunctions in neurological conditions like ALS and atypical parkinsonism. He completed a clinical fellowship at Baycrest Academy for Research and Education (affiliated with the University of Toronto) as a Bresver Family Fellow. Dr. Lahiri’s research focuses on fluid biomarkers, emerging Alzheimer’s therapies, and neuromodulation techniques like Transcranial Direct Current Stimulation (tDCS). He has published extensively on dementia, cognitive dysfunction, and neurological disorders. Key awards include the Sandra Black Award and Young Investigator Award from the Academy of Aphasia. His teaching activities are extensive, with involvement in medical and neurology residency programs. Clinically, he specializes in telemedicine for behavioral dysfunctions in dementia, having contributed to the Virtual Behavioral Medicine (VBM) program at Baycrest. He has also received travel scholarships and grants supporting his academic contributions.

Eva Kaufmannمشاهده پروفایل

استادیار

• Trained Immunity
• Immunology
• Infectious Diseases
• +۷ مورد دیگر

Dr. Eva Kaufmann is an Assistant Professor in the Department of Biomedical and Molecular Sciences at Queen's University, cross-appointed to the Translational Institute of Medicine (TIME). Her research focuses on trained immunity mechanisms in infection, vaccination, and asthma, with additional interests in public health and hospital infection control. Education: DVM (2006-2012), Justus-Liebig-University Giessen, Germany PhD in Immunology (2012-2016), Paul Ehrlich Institute & Justus-Liebig-University Giessen Postdoctoral Fellowship (2016-2022), McGill University Research Interests: Trained immunity in infection and vaccination Host-pathogen interactions in tuberculosis BCG vaccination cross-protection Immune tolerance mechanisms Inflammatory responses in chronic diseases Public health systems improvement Key Research Trends: Her work bridges basic immunology with clinical applications, emphasizing how innate immune training shapes resistance to pathogens like Mycobacterium tuberculosis and influenza. Recent studies highlight vaccination-induced protective memory and metabolic pathways governing disease tolerance. Work on SARS-CoV-2 revealed limitations of BCG cross-protection but identified obesity's role in impaired antiviral defense. Lab Team: Supervises six researchers including Gabriella Stefan, Vidthiya Jeyanathan, and Conrad Pietrzak. Collaborates on Duchenne muscular dystrophy immunology and diaphragm macrophage dynamics.

Philip Osdobyمشاهده پروفایل

استاد

• Bone Biology
• Cellular Immunology
• Regenerative Medicine
• +۳ مورد دیگر

Philip Osdoby is a Professor in the Department of Biology at Washington University. His research focuses on bone development, pathological bone loss, and regenerative medicine, particularly cell-based therapies and tissue engineering. He investigates cell-molecular interactions involving osteoclasts, osteoblasts, immune cells, and vascular cells, emphasizing endocrine and local signaling pathways. His work spans bone biology, cellular immunology, and molecular mechanisms underlying skeletal disorders. Key areas include osteoclastogenesis regulation, cytokine signaling (e.g., IL-1, TNF-α), chemokine receptor (CXCR4) roles in osteoclast recruitment, and biomineralization processes. He explores autocrine feedback mechanisms (e.g., iNOS/NO pathways) and the interplay between angiogenesis and bone resorption in vivo models like the chick chorioallantoic membrane. Publications highlight osteoclast formation from RAW 264.7 cells, galectin-3 isoforms, and SDF-1-driven osteoclast migration. His studies often integrate in vitro and in vivo approaches to dissect bone cell microenvironment dynamics. Philip Osdoby holds no explicitly listed scientific awards. His lab’s research has contributed to understanding osteoporosis, inflammatory bone diseases, and regenerative strategies for bone repair.

• Structural Heart Disease
• Transcatheter Valve Therapy
• Interventional Cardiology
• +۲ مورد دیگر

Dr. Jubin P Joseph is a Clinical Assistant Professor of Medicine at the Keck School of Medicine of the University of Southern California and serves as Director of Structural Interventions in the Cardiac & Vascular Institute. An interventional cardiologist specializing in structural heart disease, he leads advanced transcatheter valve therapies and clinical research initiatives at USC. His educational journey includes: Undergraduate studies at Cambridge University (2005) Medical degree from Oxford University (2008) Internal medicine and cardiology training in England PhD in invasive physiology research from St Thomas' Hospital, London Advanced structural intervention fellowship at Oxford University Hospitals Specialized training at Cedars-Sinai Medical Center (2020-2022) Dr. Joseph's research centers on structural heart disease mechanisms and transcatheter interventions, with particular focus on valve pathophysiology, hemodynamic assessments, and device innovation. His clinical expertise spans transcatheter aortic/mitral/tricuspid valve replacements, MitraClip procedures, left atrial appendage occlusion, and congenital defect closures. He integrates cardiovascular physiology with structural interventions to optimize patient outcomes in complex valve disease. His publication record reveals consistent advancement in transcatheter valve therapy, emphasizing hemodynamic outcomes, imaging guidance, and novel device applications. Recent work demonstrates leadership in TAVR optimization, mitral repair techniques, and physiological assessment during interventions, reflecting his dual commitment to clinical innovation and scientific rigor. Major recognitions include: Peel and Rothwell Jackson Postgraduate Fellowship (2020-2021) European Society of Cardiology's Cardiologist of Tomorrow (2014-2017) Royal College of Surgeons' Preiskel Prize (2008) Multiple medical education travel awards (2008) Cambridge University's Preparing for Patients Prize (2003) As a clinical investigator, Dr. Joseph actively contributes to national multicenter trials while directing structural interventions at USC's Cardiac & Vascular Institute. His team pioneers emerging transcatheter therapies through rigorous physiological assessment and device evaluation, with ongoing research in microvascular dysfunction and next-generation valve technologies. The structural interventions program under his leadership focuses on complex valve disease management, combining cutting-edge transcatheter approaches with comprehensive physiological evaluation to advance structural heart care.

• Food Science
• Protein Chemistry
• Immunology
• +۳ مورد دیگر

Prof. Harry Wichers is a Professor at Wageningen University & Research, specializing in Food Quality and Design. His work focuses on protein chemistry, immunology, and food allergy mechanisms. He leads projects exploring how food processing affects protein digestibility and immunogenicity, with a particular emphasis on infant nutrition and dairy/plant protein substitutes. Research interests include the Maillard reaction's impact on protein properties, allergen formation, and macrophage activation pathways. His studies often involve in vitro digestion models and collaborations with industry. Key contributions include evaluating plant-based infant formula alternatives and understanding heated milk proteins' tolerance in allergic children. Over 296 publications and 25 active projects highlight his extensive research portfolio. Supervised 20+ PhD candidates, including work on goat milk proteins, soy glycated peptides, and AGEs in neurodegeneration. Media engagements emphasize China-Dutch agricultural cooperation and food allergy trends.

Baldwin Wayمشاهده پروفایل

استاد

• Social Psychology
• Health Psychology
• Neuroimmunology
• +۷ مورد دیگر

Dr. Baldwin Way is a Professor of Social Psychology at The Ohio State University. He leads the Social and Affective Immunology Lab (S.A.I.L.), focusing on bidirectional relationships between psychological factors and immune system function. His work integrates social psychology with pharmacology, genetics, and neuroimaging, emphasizing neurochemical mechanisms like oxytocin, opioids, and serotonin. Education: PhD in Social Psychology from UCLA (2003), AB from Dartmouth College (1994). Research topics include stress resilience, social media’s impact on inflammation, and drug effects on socio-emotional processes. He leads NIH-funded projects (R01MH135501, R01DA042080) exploring geospatial stress exposure, neighborhood influences on adolescent brain development, and religious involvement’s health benefits. Key interests span translational research linking mind-body interactions, including repurposing acetaminophen for mental health conditions like borderline personality disorder. Ongoing projects investigate inflammation’s role in depression and substance use, leveraging GPS tracking and biosensor data. Dr. Way’s lab emphasizes interdisciplinary collaboration and community engagement to address health disparities. Publications highlight groundbreaking findings on acetaminophen’s dampening effects on empathy and trust, as well as genetic influences on stress responses (e.g., 5-HTTLPR polymorphism studies). He advises graduate students like G.R.O. Durso and D. Mischkowski, and collaborates with institutions worldwide. Future work focuses on digital health interventions and neurobiological pathways underpinning resilience.

Mark Rossمشاهده پروفایل

دانشیار

• Immunology
• Exercise Physiology
• Ageing
• +۶ مورد دیگر

Mark Ross is an Associate Professor at Heriot-Watt University, affiliated with the School of Energy, Geoscience, Infrastructure and Society and the Institute for Life and Earth Sciences. He holds roles as Director of Research for the Sport and Exercise Science department and Programme Director for the BSc (Hons) Sport and Exercise Science. He chairs the EGIS Research Ethics Committee and previously served as Programme Leader at Edinburgh Napier University. Education includes a 1st Class Honours Degree in Sport and Exercise Science from Heriot-Watt University (2009, awarded James Watt Medal), an MRes in Exercise Physiology from Waterford Institute of Technology (2011), and a PhD in Exercise Physiology from Edinburgh Napier University (focused on endothelial progenitor cells). His research explores immune cell contributions to inflammation and tissue repair, leveraging exercise as a modulator. Techniques include flow cytometry to study immune cell activation in human samples from exercise studies. Key interests span T-cells, macrophages, aging, and exercise-induced immunological changes. Recent articles highlight work on ultra-endurance exercise's effects on T-cells, vascular aging in centenarians, and exercise-induced progenitor cell mobilization. His studies often integrate clinical, immunological, and physiological perspectives. Awards: James Watt Medal (2009) PhD projects include exercise's role in T-cell-mediated inflammation, immune health in athletes, and exercise in inflammatory conditions. He actively seeks research grants and collaborates on global projects like VascAgeNet. His work contributes to UN SDGs related to health and longevity. Labs/Teams: Active within the Institute for Life and Earth Sciences, collaborating on vascular aging, exercise immunology, and cardiometabolic disease research.

Young-Eun Choمشاهده پروفایل

استادیار

• Biomarker Research
• Extracellular Vesicles
• Obesity
• +۷ مورد دیگر

Dr. Young-Eun Cho is an Assistant Professor at the University of Iowa, specializing in biomarker research related to obesity, cardiovascular complications, and extracellular vesicles (EVs). Her work integrates molecular biology, genomics, and clinical studies to explore EV cargo in kidney transplant recipients, breast cancer survivors, and maternal-infant health. Postdoc: University of Illinois at Chicago College of Medicine & NIH PhD: Yonsei University College of Medicine BSN: Yonsei University College of Nursing Dr. Cho's research focuses on EVs as mediators of intercellular communication, particularly in obesity-related weight gain post-kidney transplantation and maternal EVs' impact on childhood obesity. She employs omics methodologies (mRNA, miRNA, DNA methylation) to identify biomarkers in PTSD, TBI, and stroke patients. Her recent publications highlight EVs' roles in sleep-amyloid β interactions, endothelial protection via breast milk, and miRNA responses to dietary interventions. At the University of Iowa, her lab (MedLab building) investigates maternal EVs from placenta and breastmilk to combat childhood obesity.

• Metabolic Dysfunction
• Calcium Signaling
• Liver Diseases
• +۳ مورد دیگر

Mateus Guerra, PhD, is a Senior Staff Scientist at the Yale School of Medicine, Department of Medicine (Digestive Diseases). He holds appointments in Digestive Diseases and is affiliated with the Center for Cellular and Molecular Imaging (CCMI). His research focuses on calcium signaling pathways in liver pathophysiology, metabolic dysfunction-associated steatohepatitis (NASH), and mitochondrial biology. Guerra earned his PhD in Pharmacology from the Federal University of Minas Gerais (2010), with a visiting research stint at Università di Roma La Sapienza (2008), and earlier degrees including an MSc in Biochemical Pharmacology (2004) and BS in Pharmacy (2000). Key research interests include the role of cytosolic calcium in hepatic metabolism, neutrophil-mediated liver injury in alcoholic hepatitis, and lipid droplet cholesterol regulation in NASH. His work integrates molecular biology, cell signaling, and advanced imaging techniques to study liver diseases. Collaborations with prominent researchers like Michael H. Nathanson and Gerald I. Shulman highlight his contributions to translational hepatology. Guerra's lab at the CCMI explores cellular mechanisms linking metabolic stress and liver injury, with recent studies published in Proceedings of the National Academy of Sciences , Cell Metabolism , and Journal of Clinical Investigation . His research has identified novel therapeutic targets for NASH and alcohol-related liver diseases through insights into mitochondrial calcium dynamics and lipid droplet biology. No scientific awards are explicitly listed, but his extensive publication record underscores peer recognition. He advises a collaborative network of researchers but no named students are documented here. Funding sources and grants are not specified in the provided text.

• Virology
• Infectious Diseases
• Molecular Medicine
• +۳ مورد دیگر

Mia Madel Alfajaro is an Associate Research Scientist at the Yale School of Medicine. She holds a DVM from the University of the Philippines College of Veterinary Medicine, and a PhD and MS in Molecular Medicine from Chonnam National University. Her research focuses on viral pathogenesis, host-virus interactions, and antiviral strategies, with a particular emphasis on norovirus, SARS-CoV-2, and rotavirus. Dr. Alfajaro collaborates extensively with leading researchers in virology and immunology, including Craig B. Wilen, Akiko Iwasaki, and Madison Strine. Her work combines molecular biology, CRISPR screening, and animal models to uncover mechanisms of viral persistence and immune evasion. Recent studies include identifying NINJ1 as a host factor hijacked by norovirus for protein secretion and demonstrating how bat-derived SARS-CoV-2 variants evade human immunity. She has also elucidated the role of intestinal tuft cells in norovirus persistence and explored pharmacological interventions targeting epigenetic regulators to block viral replication. Dr. Alfajaro’s research spans from basic virology to translational studies, including developing human iPSC-based COPD models to predict SARS-CoV-2 outcomes. Her contributions have advanced understanding of viral entry mechanisms, host dependency factors, and immune responses to emerging pathogens. She is affiliated with the Wilen Lab at Yale, focusing on interdisciplinary approaches to combat viral infections.